Waldenstrom’s macroglobulinemia
Waldenstrom’s macroglobulinemia (WM) is very distinct from other indolent lymphoma subtypes: by definition it is accompanied by a monoclonal IgM gammopathy, it presents always with bone marrow infiltration and often with clinical symptoms such as neuropathy or hyperviscosity. These disease characteristics and the frequently advanced age of the WM patient pose a major challenge to the treating clinician even today.
Contact
Comprehensive Cancer Center Ulm
University Hospital Ulm
Prof. Dr. C. Buske
University Hospital Ulm
Prof. Dr. C. Buske
| Phone: | +49 (0) 731 - 500 65801 | |
| Fax: | +49 (0) 731 - 500 65822 |
News/Publications
Systematic Literature Review of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia - Need for a Disease-Specific Tool.
Bristogiannis, Sotirios, Jahanzaib Khwaja, Yadanar Lwin, Encarl Uppal, Shirley D'Sa, and Charalampia Kyriakou.
eJHaem n/a, no. n/a
Plain Language Summary of the Innovate Study: Ibrutinib Plus Rituximab Is Well-Tolerated and Effective in People with Waldenström's Macroglobulinemia
Buske, C., A. Tedeschi, J. Trotman, R. García-Sanz, D. MacDonald, V. Leblond, B. Mahe, C. Herbaux, J. V. Matous, C. S. Tam, L. T. Heffner, M. Varettoni, M. L. Palomba, C. Shustik, E. Kastritis, S. P. Treon, J. Ping, B. Hauns, I. Arango-Hisijara, and M. A. Dimopoulos.
Future Oncol (Feb 23 2023).